Phenobarbital for the management of severe acute alcohol withdrawal (the PHENOMANAL trial): a pilot randomized controlled trial

Abstract Background Benzodiazepines are considered first-line treatment for patients experiencing severe acute alcohol withdrawal syndrome (sAAWS). Although several medications have been evaluated as potential adjuvant treatments for sAAWS, barbiturates show particular promise. Objective In the PHEN...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Niall Filewod, Stephen Hwang, Christian J. Turner, Leena Rizvi, Sara Gray, Michelle Klaiman, Danielle Buell, Johnathan Ailon, Alexander Caudarella, Galo F. Ginocchio, Marlene Santos, Gyan Sandhu, Norman Dewhurst, Kelly Sequeira, Karen E. A. Burns
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2022-01-01
Edice:	Pilot and Feasibility Studies
Témata:	Phenobarbital; Alcohol withdrawal Delirium tremens Treatment
On-line přístup:	https://doi.org/10.1186/s40814-021-00963-4
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!